The approval was based on additional efficacy data from the ACCESS IUS trial. The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Liletta ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results